Shanghai Henlius Biotech, Inc. Class H (2696) Income Statement

7 Followers

Shanghai Henlius Biotech, Inc. Class H Income Statement

Last quarter (Q2 2025), Shanghai Henlius Biotech, Inc. Class H's total revenue was ¥1.41B, an increase of 2.67% from the same quarter last year. In Q2, Shanghai Henlius Biotech, Inc. Class H's net income was ¥195.06M. See Shanghai Henlius Biotech, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	¥ 6.67B	¥ 5.72B	¥ 5.39B	¥ 3.21B	¥ 1.68B
Gross Profit	¥ 4.98B	¥ 4.18B	¥ 3.92B	¥ 2.37B	¥ 1.16B
Operating Expenses	¥ 4.17B	¥ 3.25B	¥ 3.29B	¥ 3.00B	¥ 1.82B
Depreciation and Amortization	¥ 346.05M	¥ 279.63M	¥ 279.63M	¥ 277.60M	¥ 200.18M
EBITDA	¥ 1.16B	¥ 1.15B	¥ 911.33M	¥ -310.61M	¥ -671.74M
Operating Income	¥ 817.12M	¥ 939.13M	¥ 631.70M	¥ -628.53M	¥ -665.25M
Other Income/Expenses	¥ -5.40M	¥ -93.25M	¥ -62.13M	¥ -65.36M	¥ -291.49M
Pretax Income	¥ 811.72M	¥ 845.88M	¥ 569.58M	¥ -693.89M	¥ -956.74M
Net Income	¥ 827.04M	¥ 820.47M	¥ 546.02M	¥ -695.26M	¥ -984.05M
Per Share Metrics
Basic EPS	¥ 1.52	¥ 1.51	¥ 1.01	¥ -1.28	¥ -1.83
Diluted EPS	¥ 1.51	¥ 1.51	¥ 1.00	¥ -1.28	¥ -1.83
Weighted Average Shares Outstanding	547.71M	543.50M	546.02M	542.02M	537.73M
Weighted Average Shares Outstanding (Diluted)	545.93M	543.49M	543.37M	542.02M	538.84M

Currency in CNY

Shanghai Henlius Biotech, Inc. Class H (2696) Income Statement

Shanghai Henlius Biotech, Inc. Class H Income Statement

Shanghai Henlius Biotech, Inc. Class H Earnings and Revenue History